AXSM · NASDAQ · STOCK
Axsome Therapeutics, Inc.
$215.92
52W $103.40 – $260.19
55/100
$11.10B
-57.5
0.60
Is AXSM Bullish or Bearish?
Mixed.
Innellis AI committee rates Axsome Therapeutics, Inc. (AXSM) Watch with a composite score of 55/100
, based on 4 analysts with 50% agreement.
Last updated August 11, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +4.74 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -15.26 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — bollinger bandwidth of 20.4% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- VIX regime is low -- calm backdrop supports risk-taking — Macro
- Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
- MACD histogram negative -- bearish momentum — Technical
- Bollinger bandwidth of 20.4% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of August 11, 2026
Overall Committee Score
55/100
Agreement
50%
Analysts
4
Conviction
Contested
Sector Rank
Top 79%
of 192 Healthcare peers
Technical Analyst
neutral
48
/ 100 · High confidence
Mixed or range-bound price action
− MACD histogram negative -- bearish momentum
Risk Analyst
bearish
35
/ 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− Bollinger bandwidth of 20.4% signals elevated volatility
Macro Analyst
bullish
78
/ 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ VIX regime is low -- calm backdrop supports risk-taking
News Analyst
bullish
60
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
Portfolio Manager
neutral
55
/ 100 · Moderate confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− 2 existing position pair(s) are highly correlated already
Technical Analysis
RSI (14)
41.5
Neutral
MACD Histogram
-1.240
Bearish Momentum
Trend Direction
Sideways
Weekly: Uptrend
Market Structure
Mixed
Support
$152.55
Resistance
$257.81
Bollinger %B
0.27
Inside Bands
Price vs Moving Averages
EMA 9
$218.29
Below
EMA 21
$224.84
Below
EMA 50
$227.42
Below
EMA 200
$193.44
Above
Fundamental Analysis
Valuation
67
Profitability
25
Financial Health
26
Cash Flow
15
Valuation
P/E Ratio
-57.5×
P/B Ratio
133.39×
PEG Ratio
-2.02
Dividend Yield
0.00%
52W High
$260.19
52W Low
$103.40
Quality & Growth
ROE
-20745.7%
ROA
-2655.5%
Gross Margin
9323.6%
Operating Margin
-2427.9%
Revenue Growth YoY
—
Debt / Equity
2.63
AI Fundamental Assessment
[reduced confidence: limited earnings history] P/E ratio of -57.5 (inexpensive relative to a 15-40x range); Price-to-book of 133.4x; PEG ratio of -2.0 (under 1.0 suggests growth is undervalued relative to price); Return on equity of -207.5%; Return on assets of -26.6%; Net margin of -24.7%; Gross margin of 93.2%; Current ratio of 1.43 (tight short-term liquidity); Debt-to-equity of 2.63; Free cash flow per share is negative (-1.39); Earnings-history trend unavailable; growth based on TTM year-over-year only.
Get the Full AXSM Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →